CUVL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 5.19 USD -0.95% Market Closed

Market Cap: $261.7m

	Clinuvel Pharmaceuticals Ltd NASDAQ:CUVL	AU
J	JANU PUTRA SEJAHTERA Tbk PT IDX:AYAM	ID
T	Thai Polycons PCL SET:TPOLY	TH
	Waratah Minerals Ltd F:0FS0	AU

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

95%

Declining Gross Margin

94% > 83%

Exceptional Operating Margin

43%

Strong 3Y Average Operating Margin

51%

Declining Operating Margin

56% > 43%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

38%

Declining Net Margin

39% > 36%

Exceptional Free Cash Flow Margin

38%

Strong 3Y Average Free Cash Flow Margin

38%

Declining Free Cash Flow Margin

46% > 38%

Positive ROE

13%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

104%

Declining ROIC

122% > 81%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.